> If it is simply "lessoning" the symptoms which has not been my experience with Omicron, but not preventing transmission then the authorizations should be pull

> If it is simply "lessoning" the symptoms which has not been my experience with Omicron, but not preventing transmission then the authorizations should be pulled until they can be resubmitted. Are organizations still making policy decisions based on the specifics of the original application implications? Or from observation that it only notably reduces hospitalizations / symptom severity? If the former is the case, that would warrant clarity, but I also have no idea what a resubmission process looks like. Is that a one week turnaround? Or is it six months with no vaccines being able to be distributed?